| NCT00106769 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Vaccine to Prevent West Nile Virus Disease
|
PHASE1 |
View
|
| NCT00106756 |
|
National Eye Institute (NEI) |
COMPLETED |
Clinical and Genetic Studies of Familial Exudative Vitreoretinopathy
|
|
View
|
| NCT00106704 |
|
Merck Sharp & Dohme LLC |
COMPLETED |
Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)
|
PHASE3 |
View
|
| NCT00106561 |
Positive Gene Therapy |
Melbourne Health |
COMPLETED |
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
|
PHASE2 |
View
|
| NCT00106535 |
|
Hoffmann-La Roche |
COMPLETED |
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)
|
PHASE3 |
View
|
| NCT00106457 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
20 Year Changes in Fitness & Cardiovascular Disease Risk - Ancillary to CARDIA
|
|
View
|
| NCT00106418 |
|
Celgene |
COMPLETED |
A Research Study for Patients With Prostate Cancer
|
PHASE2 |
View
|
| NCT00106405 |
|
Forest Laboratories |
COMPLETED |
An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
|
PHASE2 |
View
|
| NCT00106392 |
|
Astellas Pharma Inc |
COMPLETED |
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
|
PHASE4 |
View
|
| NCT00106366 |
|
Novo Nordisk A/S |
COMPLETED |
Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes
|
PHASE3 |
View
|
| NCT00106327 |
|
Northwestern University |
COMPLETED |
Improving Functioning in Peripheral Arterial Disease
|
NA |
View
|
| NCT00106158 |
|
Ludwig Institute for Cancer Research |
COMPLETED |
Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1
|
PHASE1 |
View
|
| NCT00106132 |
|
National Eye Institute (NEI) |
COMPLETED |
Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage
|
PHASE3 |
View
|
| NCT00106106 |
|
National Institutes of Health Clinical Center (CC) |
COMPLETED |
Acamprosate to Reduce Symptoms of Alcohol Withdrawal
|
PHASE2 |
View
|
| NCT00106093 |
|
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
COMPLETED |
Alcoholism Assessment and Treatment
|
|
View
|
| NCT00106067 |
|
US Department of Veterans Affairs |
COMPLETED |
Aging and Family Outcomes in Supportive Care of Advanced Cancer Patients
|
NA |
View
|
| NCT00106002 |
|
Eli Lilly and Company |
COMPLETED |
Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer
|
PHASE2 |
View
|
| NCT00105950 |
|
GlaxoSmithKline |
COMPLETED |
Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer
|
PHASE2 |
View
|
| NCT00105859 |
|
US Department of Veterans Affairs |
TERMINATED |
Preventing Pressure Ulcers in Veterans With Spinal Cord Injury (SCI)
|
NA |
View
|
| NCT00105833 |
|
US Department of Veterans Affairs |
COMPLETED |
Improving Outcomes of Depression in Primary Care
|
NA |
View
|
| NCT00105820 |
|
US Department of Veterans Affairs |
COMPLETED |
Evaluation Study of TIDES Depression Care Quality Improvement Intervention
|
NA |
View
|
| NCT00105794 |
|
US Department of Veterans Affairs |
COMPLETED |
Psychiatric Advance Directives for Improved Mental Health Care
|
NA |
View
|
| NCT00105768 |
|
US Department of Veterans Affairs |
COMPLETED |
Effectiveness of Advisor-Teller Money Manager
|
PHASE1 |
View
|
| NCT00105703 |
|
US Department of Veterans Affairs |
COMPLETED |
Evaluation of a Nurse Case Management Model for Chronic Heart Failure
|
NA |
View
|
| NCT00105651 |
|
US Department of Veterans Affairs |
COMPLETED |
A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer
|
NA |
View
|
| NCT00105612 |
|
National Institute on Aging (NIA) |
COMPLETED |
Memory Aid for Informed Consent in Alzheimer's Research
|
NA |
View
|
| NCT00105560 |
|
Massachusetts General Hospital |
COMPLETED |
Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma
|
NA |
View
|
| NCT00105534 |
|
Merck Sharp & Dohme LLC |
COMPLETED |
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)
|
PHASE3 |
View
|
| NCT00105495 |
|
ApoPharma |
COMPLETED |
Efficacy Study in Removing Excess Iron From the Heart
|
PHASE4 |
View
|
| NCT00105469 |
|
Merck Sharp & Dohme LLC |
COMPLETED |
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
|
PHASE3 |
View
|
| NCT00105456 |
|
Genentech, Inc. |
COMPLETED |
A Study of Patients With HER2-Positive Metastatic Breast Cancer
|
|
View
|
| NCT00105404 |
|
National Eye Institute (NEI) |
COMPLETED |
Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation
|
PHASE3 |
View
|
| NCT00105235 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
|
PHASE2 |
View
|
| NCT00105157 |
|
Merck Sharp & Dohme LLC |
COMPLETED |
Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)
|
PHASE2 |
View
|
| NCT00105118 |
|
National Institute of Mental Health (NIMH) |
COMPLETED |
Effect of Transcranial Magnetic Stimulation on Memory
|
|
View
|
| NCT00105105 |
|
Corcept Therapeutics |
TERMINATED |
Mifepristone as Adjunctive Therapy in Alzheimer's Disease
|
PHASE2 |
View
|
| NCT00105092 |
|
Eli Lilly and Company |
COMPLETED |
Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.
|
PHASE2 |
View
|
| NCT00105066 |
|
National Institute on Aging (NIA) |
COMPLETED |
The Effects of Metformin on Blood Vessel Structure and Function
|
PHASE2 |
View
|
| NCT00104858 |
|
Fred Hutchinson Cancer Center |
COMPLETED |
Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
|
PHASE2 |
View
|
| NCT00104793 |
|
Japan Multinational Trial Organization |
COMPLETED |
Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer
|
PHASE2 |
View
|
| NCT00104767 |
|
Jonsson Comprehensive Cancer Center |
COMPLETED |
Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
|
PHASE1 |
View
|
| NCT00104702 |
|
UNICANCER |
COMPLETED |
Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer
|
PHASE2 |
View
|
| NCT00104650 |
|
Amgen |
COMPLETED |
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates
|
PHASE2 |
View
|
| NCT00104559 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
UNKNOWN |
Computer-Generated Vs. Standard Informed Consent for HIV Research Studies
|
NA |
View
|
| NCT00104533 |
|
Javeriana University |
COMPLETED |
Effectiveness of Magnetic Therapy on Pain Intensity
|
PHASE3 |
View
|
| NCT00104520 |
|
Gilead Sciences |
COMPLETED |
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
|
PHASE3 |
View
|
| NCT00104494 |
|
Cystic Fibrosis Foundation |
COMPLETED |
Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)
|
NA |
View
|
| NCT00104468 |
|
SGX Pharmaceuticals, Inc. |
TERMINATED |
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)
|
PHASE1 |
View
|
| NCT00104403 |
|
GlaxoSmithKline |
COMPLETED |
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
|
PHASE2 |
View
|
| NCT00104260 |
|
BioMarin Pharmaceutical |
COMPLETED |
Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria
|
PHASE2 |
View
|
| NCT00104234 |
|
BioMarin Pharmaceutical |
COMPLETED |
Study of rhASB in Patients With Mucopolysaccharidosis VI
|
PHASE3 |
View
|
| NCT00104195 |
|
NYU Langone Health |
COMPLETED |
A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions
|
|
View
|
| NCT00104169 |
|
National Institute on Aging (NIA) |
TERMINATED |
Idiopathic Anemia of Aging (IAA)
|
PHASE2 |
View
|
| NCT00104156 |
|
National Center for Complementary and Integrative Health (NCCIH) |
COMPLETED |
Qigong Therapy for Individuals With Knee Osteoarthritis
|
PHASE2 |
View
|
| NCT00104104 |
|
Novartis Pharmaceuticals |
COMPLETED |
A Multiple Myeloma Trial in Patients With Bone Metastases
|
PHASE4 |
View
|
| NCT00103961 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
An Observational Study of People Who Have Recently Been Infected With HIV
|
|
View
|
| NCT00103935 |
|
AstraZeneca |
COMPLETED |
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
|
PHASE2 |
View
|
| NCT00103857 |
|
Merck Sharp & Dohme LLC |
COMPLETED |
MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)
|
PHASE3 |
View
|
| NCT00103818 |
|
H. Lundbeck A/S |
COMPLETED |
An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)
|
PHASE3 |
View
|
| NCT00103805 |
|
University Hospital Muenster |
COMPLETED |
Improved Language Acquisition With Levodopa
|
PHASE4 |
View
|
| NCT00103792 |
|
University Medical Center Groningen |
COMPLETED |
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
|
PHASE3 |
View
|
| NCT00103766 |
|
O'Brien, Jeana D., MD, FACP, FCCP |
UNKNOWN |
Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion
|
NA |
View
|
| NCT00103558 |
|
Biogen |
COMPLETED |
Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
|
PHASE1 |
View
|
| NCT00103532 |
|
University of North Carolina, Chapel Hill |
COMPLETED |
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
|
NA |
View
|
| NCT00103493 |
|
Temple University |
COMPLETED |
Oral Health Education Program
|
PHASE3 |
View
|
| NCT00103467 |
|
VaxGen |
COMPLETED |
Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine
|
PHASE1 |
View
|
| NCT00103402 |
|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
COMPLETED |
Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
PHASE3 |
View
|
| NCT00103350 |
Positive Gene Therapy |
TargeGen |
COMPLETED |
Safety of TG100-115 for Heart Attack Treated With Angioplasty
|
PHASE1 |
View
|
| NCT00103259 |
|
National Cancer Institute (NCI) |
COMPLETED |
Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
|
PHASE2 |
View
|
| NCT00103233 |
Positive Gene Therapy |
SWOG Cancer Research Network |
COMPLETED |
Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer
|
PHASE3 |
View
|
| NCT00103220 |
|
National Cancer Institute (NCI) |
COMPLETED |
SJG-136 in Treating Patients With Advanced Solid Tumors
|
PHASE1 |
View
|
| NCT00103194 |
|
National Cancer Institute (NCI) |
COMPLETED |
Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer
|
PHASE2 |
View
|
| NCT00103168 |
|
European Organisation for Research and Treatment of Cancer - EORTC |
COMPLETED |
Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
|
PHASE3 |
View
|
| NCT00103103 |
|
California Cancer Consortium |
TERMINATED |
Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
|
PHASE2 |
View
|
| NCT00103051 |
|
European Organisation for Research and Treatment of Cancer - EORTC |
COMPLETED |
Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer
|
PHASE2 |
View
|
| NCT00102960 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
|
PHASE3 |
View
|
| NCT00102934 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
UNKNOWN |
Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus
|
NA |
View
|
| NCT00102895 |
|
Pfizer |
TERMINATED |
A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer
|
PHASE2 |
View
|
| NCT00102869 |
|
University Hospital Muenster |
COMPLETED |
Dopaminergic Enhancement of Learning and Memory in Aphasia
|
PHASE4 |
View
|
| NCT00102856 |
|
University Hospital Muenster |
SUSPENDED |
Neuromodulation and Language Acquisition (Stage Ib)
|
PHASE4 |
View
|
| NCT00102804 |
|
Eli Lilly and Company |
COMPLETED |
Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)
|
PHASE3 |
View
|
| NCT00102661 |
Positive Gene Therapy |
M.D. Anderson Cancer Center |
COMPLETED |
Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia
|
PHASE2 |
View
|
| NCT00102635 |
|
M.D. Anderson Cancer Center |
TERMINATED |
4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)
|
PHASE1 |
View
|
| NCT00102557 |
|
National Institute of Dental and Craniofacial Research (NIDCR) |
COMPLETED |
Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus
|
PHASE2 |
View
|
| NCT00102518 |
|
Otsuka Pharmaceutical Development & Commercialization, Inc. |
COMPLETED |
Aripiprazole Open-Label, Safety and Tolerability Study
|
PHASE3 |
View
|
| NCT00102505 |
Positive Gene Therapy |
Pharmacyclics LLC. |
COMPLETED |
A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
|
PHASE1 |
View
|
| NCT00102492 |
|
GlaxoSmithKline |
COMPLETED |
Study Of GW679769 In Major Depressive Disorder
|
PHASE2 |
View
|
| NCT00102466 |
|
Novartis Pharmaceuticals |
COMPLETED |
Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
|
PHASE3 |
View
|
| NCT00102427 |
|
University of Pittsburgh |
COMPLETED |
Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders
|
PHASE2 |
View
|
| NCT00102258 |
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
COMPLETED |
Role of Nutrition and Hormones in Boys With Disordered Growth
|
PHASE2 |
View
|
| NCT00102232 |
Positive Gene Therapy |
Wageningen Centre for Food Sciences |
COMPLETED |
Effect of Phosphatidylcholine on Plasma Homocysteine in Healthy Volunteers
|
NA |
View
|
| NCT00102193 |
|
Otsuka America Pharmaceutical |
COMPLETED |
Study for the Treatment of Ulcerative Colitis With Adacolumn
|
PHASE3 |
View
|
| NCT00102167 |
|
H. Lundbeck A/S |
COMPLETED |
Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)
|
PHASE3 |
View
|
| NCT00102128 |
|
Genzyme, a Sanofi Company |
TERMINATED |
Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.
|
PHASE2 |
View
|
| NCT00102102 |
|
National Institute of Mental Health (NIMH) |
COMPLETED |
Role of Substance P in Post-Traumatic Stress Disorder
|
|
View
|
| NCT00102050 |
|
Nissan Chemical Industries |
COMPLETED |
Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication
|
PHASE2 |
View
|
| NCT00101959 |
|
EMD Serono |
WITHDRAWN |
Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects
|
PHASE4 |
View
|
| NCT00101933 |
Positive Gene Therapy |
MedtronicNeuro |
COMPLETED |
SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy
|
PHASE3 |
View
|
| NCT00101920 |
|
Amgen |
COMPLETED |
ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
|
PHASE2 |
View
|
| NCT00101894 |
|
Amgen |
COMPLETED |
Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer
|
PHASE1 |
View
|
| NCT00101868 |
|
Agency for Healthcare Research and Quality (AHRQ) |
COMPLETED |
Value of Technology to Transfer Discharge Information
|
NA |
View
|
| NCT00101803 |
|
Novartis Pharmaceuticals |
COMPLETED |
Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
|
PHASE3 |
View
|
| NCT00101751 |
|
Novo Nordisk A/S |
COMPLETED |
INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study
|
PHASE4 |
View
|
| NCT00101712 |
|
Novartis Pharmaceuticals |
COMPLETED |
Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia
|
PHASE3 |
View
|
| NCT00101660 |
|
Bristol-Myers Squibb |
COMPLETED |
Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
|
PHASE2 |
View
|
| NCT00101634 |
|
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
COMPLETED |
Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia
|
PHASE3 |
View
|
| NCT00101595 |
|
Bristol-Myers Squibb |
COMPLETED |
Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
|
PHASE2 |
View
|
| NCT00101569 |
|
Otsuka Pharmaceutical Development & Commercialization, Inc. |
COMPLETED |
Aripiprazole Oral Acceptability Trial
|
PHASE3 |
View
|
| NCT00101504 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Hypertension Education and Treatment Partnership for Reducing Ethnic Differences in the Risk of Cardiovascular Disease
|
|
View
|
| NCT00101361 |
Positive Gene Therapy |
US Department of Veterans Affairs |
TERMINATED |
Oxandrolone to Heal Pressure Ulcers
|
PHASE3 |
View
|
| NCT00101335 |
|
Fox Chase Cancer Center |
COMPLETED |
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
|
PHASE2 |
View
|
| NCT00101257 |
|
Fred Hutchinson Cancer Center |
COMPLETED |
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
|
PHASE1 |
View
|
| NCT00101205 |
|
National Cancer Institute (NCI) |
TERMINATED |
Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
|
PHASE1 |
View
|
| NCT00101192 |
|
Gynecologic Oncology Group |
COMPLETED |
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
|
PHASE2 |
View
|
| NCT00101166 |
Positive Gene Therapy |
H. Lee Moffitt Cancer Center and Research Institute |
COMPLETED |
Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma
|
PHASE2 |
View
|
| NCT00100958 |
|
University of Kansas |
COMPLETED |
Indole-3-Carbinol in Preventing Cancer in Healthy Participants
|
PHASE1 |
View
|
| NCT00100932 |
|
Eisai Inc. |
COMPLETED |
Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy
|
PHASE2 |
View
|
| NCT00100893 |
|
City of Hope Medical Center |
COMPLETED |
IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
|
PHASE1 |
View
|
| NCT00100867 |
|
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
COMPLETED |
Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women
|
|
View
|
| NCT00100802 |
|
Children's Oncology Group |
COMPLETED |
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
|
PHASE2 |
View
|
| NCT00100750 |
|
National Cancer Institute (NCI) |
COMPLETED |
Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer
|
PHASE1 |
View
|
| NCT00100659 |
Positive Gene Therapy |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
COMPLETED |
PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C
|
PHASE3 |
View
|
| NCT00100633 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People
|
PHASE1 |
View
|
| NCT00100620 |
|
Novartis Pharmaceuticals |
COMPLETED |
Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis
|
PHASE3 |
View
|
| NCT00100594 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China
|
NA |
View
|
| NCT00100568 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal
|
NA |
View
|
| NCT00100503 |
|
National Institute of Neurological Disorders and Stroke (NINDS) |
COMPLETED |
Brain Reorganization Following Constraint-Induced Therapy in Children With Cerebral Palsy
|
|
View
|
| NCT00100451 |
|
US Department of Veterans Affairs |
COMPLETED |
Aging, Exercise, and Hormonal Influences of Fat Metabolism
|
NA |
View
|
| NCT00100360 |
|
National Institute of Mental Health (NIMH) |
COMPLETED |
Hormonal Causes of Menstrual-Related Mood Disorders
|
|
View
|
| NCT00100334 |
|
PRAECIS Pharmaceuticals Inc. |
COMPLETED |
Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
|
PHASE1 |
View
|
| NCT00100295 |
|
National Center for Complementary and Integrative Health (NCCIH) |
COMPLETED |
Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
PHASE2 |
View
|
| NCT00100269 |
Positive Gene Therapy |
Repromed |
COMPLETED |
Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility
|
PHASE3 |
View
|
| NCT00100256 |
|
Andarix Pharmaceuticals |
UNKNOWN |
Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy
|
PHASE1 |
View
|
| NCT00100204 |
Positive Gene Therapy |
National Institute of Dental and Craniofacial Research (NIDCR) |
COMPLETED |
Salivary Proteins in Disease and Health
|
|
View
|
| NCT00100061 |
|
National Center for Complementary and Integrative Health (NCCIH) |
UNKNOWN |
Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)
|
PHASE2 |
View
|
| NCT00100035 |
|
National Center for Complementary and Integrative Health (NCCIH) |
COMPLETED |
Polarity Therapy for American Indian Caregivers of Dementia Patients
|
PHASE1 |
View
|
| NCT00099957 |
|
Novartis Pharmaceuticals |
COMPLETED |
A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes
|
PHASE2 |
View
|
| NCT00099918 |
|
Novartis Pharmaceuticals |
COMPLETED |
Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
|
PHASE3 |
View
|
| NCT00099905 |
|
Novartis Pharmaceuticals |
COMPLETED |
A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
|
PHASE3 |
View
|
| NCT00099892 |
|
Novartis Pharmaceuticals |
COMPLETED |
Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
|
PHASE3 |
View
|
| NCT00099866 |
Positive Gene Therapy |
Novartis Pharmaceuticals |
COMPLETED |
Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
|
PHASE3 |
View
|
| NCT00099658 |
|
CIPRA SA |
UNKNOWN |
Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children
|
NA |
View
|
| NCT00099632 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy
|
PHASE2 |
View
|
| NCT00099593 |
|
University of Pittsburgh |
COMPLETED |
Immunization Against Tumor Cells in Sezary Syndrome
|
PHASE2 |
View
|
| NCT00099567 |
|
National Institute on Aging (NIA) |
COMPLETED |
Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
|
|
View
|
| NCT00099502 |
|
Bayer |
COMPLETED |
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
|
PHASE3 |
View
|
| NCT00099450 |
|
Merck Sharp & Dohme LLC |
COMPLETED |
Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers
|
PHASE1 |
View
|
| NCT00099359 |
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
COMPLETED |
Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
|
PHASE3 |
View
|
| NCT00099333 |
Positive Gene Therapy |
AstraZeneca |
COMPLETED |
Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
|
PHASE2 |
View
|
| NCT00099320 |
|
AstraZeneca |
COMPLETED |
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
|
PHASE3 |
View
|
| NCT00099294 |
|
Threshold Pharmaceuticals |
COMPLETED |
Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer
|
PHASE3 |
View
|
| NCT00099268 |
|
Novartis Pharmaceuticals |
COMPLETED |
Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
|
PHASE3 |
View
|
| NCT00099203 |
|
Hoffmann-La Roche |
TERMINATED |
A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease
|
PHASE3 |
View
|
| NCT00099151 |
|
National Institute on Aging (NIA) |
COMPLETED |
CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy
|
NA |
View
|
| NCT00099060 |
|
National Cancer Institute (NCI) |
COMPLETED |
Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme
|
PHASE1 |
View
|
| NCT00099008 |
Positive Gene Therapy |
UNC Lineberger Comprehensive Cancer Center |
COMPLETED |
Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
|
PHASE1 |
View
|
| NCT00098995 |
|
Peter MacCallum Cancer Centre, Australia |
COMPLETED |
Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
|
PHASE1 |
View
|
| NCT00098969 |
|
National Cancer Institute (NCI) |
COMPLETED |
UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants
|
PHASE1 |
View
|
| NCT00098956 |
|
National Cancer Institute (NCI) |
COMPLETED |
7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer
|
PHASE2 |
View
|
| NCT00098761 |
Positive Gene Therapy |
Pediatric Brain Tumor Consortium |
COMPLETED |
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors
|
PHASE1 |
View
|
| NCT00098735 |
|
Novartis Pharmaceuticals |
COMPLETED |
Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation
|
PHASE3 |
View
|
| NCT00098618 |
|
National Cancer Institute (NCI) |
TERMINATED |
Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
|
PHASE2 |
View
|
| NCT00098605 |
|
National Cancer Institute (NCI) |
COMPLETED |
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
|
PHASE2 |
View
|
| NCT00098566 |
|
Fred Hutchinson Cancer Center |
COMPLETED |
Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
|
|
View
|
| NCT00098527 |
|
National Cancer Institute (NCI) |
TERMINATED |
FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer
|
PHASE2 |
View
|
| NCT00098358 |
|
Critical Therapeutics |
UNKNOWN |
Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris
|
PHASE2 |
View
|
| NCT00098332 |
Positive Gene Therapy |
BioCryst Pharmaceuticals |
COMPLETED |
Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
|
PHASE1 |
View
|
| NCT00098306 |
Positive Gene Therapy |
ViiV Healthcare |
COMPLETED |
Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
|
PHASE2 |
View
|
| NCT00098293 |
|
ViiV Healthcare |
COMPLETED |
Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine
|
PHASE3 |
View
|
| NCT00098267 |
|
National Institute of Dental and Craniofacial Research (NIDCR) |
COMPLETED |
Collection of Dental Plaque and Saliva for Studies of Bacterial Colonization of Teeth
|
|
View
|
| NCT00098228 |
|
Novartis Pharmaceuticals |
COMPLETED |
Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
PHASE2 |
View
|
| NCT00098202 |
|
NICHD Global Network for Women's and Children's Health |
COMPLETED |
Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala
|
PHASE3 |
View
|
| NCT00098150 |
|
Novartis |
COMPLETED |
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis
|
|
View
|
| NCT00098059 |
|
Novartis Pharmaceuticals |
COMPLETED |
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection
|
PHASE3 |
View
|
| NCT00098033 |
|
University of Texas |
COMPLETED |
Investigation of Clofarabine in Acute Leukemias
|
PHASE2 |
View
|
| NCT00098020 |
|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
COMPLETED |
Podocyte Retinoids
|
PHASE2 |
View
|
| NCT00097994 |
|
University of Pittsburgh |
COMPLETED |
Does Menopause Matter?
|
|
View
|
| NCT00097968 |
|
Novartis Pharmaceuticals |
COMPLETED |
Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy
|
PHASE3 |
View
|
| NCT00097903 |
|
BioNumerik Pharmaceuticals, Inc. |
COMPLETED |
Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer
|
PHASE1 |
View
|
| NCT00097851 |
|
Cellxpert Biotechnology Corp. |
COMPLETED |
Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
|
PHASE2 |
View
|
| NCT00097760 |
|
Biogen |
COMPLETED |
Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis
|
PHASE2 |
View
|
| NCT00097734 |
|
Klinikum Hanover-Siloah Hospital |
UNKNOWN |
Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis
|
PHASE4 |
View
|
| NCT00097695 |
|
Shire |
COMPLETED |
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema
|
PHASE3 |
View
|
| NCT00097669 |
|
VITATOPS |
COMPLETED |
VITATOPS: A Study of VITAmins TO Prevent Stroke
|
NA |
View
|
| NCT00097656 |
|
University of North Carolina, Chapel Hill |
COMPLETED |
MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk
|
NA |
View
|
| NCT00097604 |
|
University of Washington |
COMPLETED |
Effects of Valerian on Sleep in Healthy Older Adults
|
PHASE2 |
View
|
| NCT00097461 |
|
National Institutes of Health Clinical Center (CC) |
COMPLETED |
Revising Employee Benefits for the Sake of Health
|
|
View
|
| NCT00097435 |
Positive Gene Therapy |
Human Genome Sciences Inc. |
COMPLETED |
A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C
|
PHASE2 |
View
|
| NCT00097357 |
|
Bristol-Myers Squibb |
COMPLETED |
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
|
PHASE2 |
View
|
| NCT00097318 |
|
National Institute of Neurological Disorders and Stroke (NINDS) |
COMPLETED |
Safety Study of Interferon Beta 1a to for Acute Stroke
|
PHASE1 |
View
|
| NCT00097305 |
|
National Center for Complementary and Integrative Health (NCCIH) |
COMPLETED |
Body-Oriented Therapy for Sexual Abuse Recovery
|
PHASE2 |
View
|
| NCT00097292 |
|
University of South Florida |
RECRUITING |
TrialNet Pathway to Prevention of T1D
|
|
View
|
| NCT00097266 |
|
Otsuka Pharmaceutical Development & Commercialization, Inc. |
COMPLETED |
Study of Aripiprazole in Patients With Acute Bipolar Mania
|
PHASE3 |
View
|
| NCT00097227 |
|
Eli Lilly and Company |
COMPLETED |
Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
|
PHASE2 |
View
|
| NCT00097058 |
|
Stanford University |
COMPLETED |
Estrogen Use in Protection From Cognitive Decline
|
|
View
|
| NCT00097032 |
|
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
COMPLETED |
Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients
|
PHASE3 |
View
|
| NCT00097006 |
Positive Gene Therapy |
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Retrovirus Epidemiology Donor Study-II (REDS-II)
|
|
View
|
| NCT00096993 |
|
Genentech, Inc. |
COMPLETED |
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
|
PHASE2 |
View
|
| NCT00096967 |
|
Genentech, Inc. |
COMPLETED |
A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study
|
PHASE3 |
View
|
| NCT00096902 |
|
National Institute of Neurological Disorders and Stroke (NINDS) |
COMPLETED |
Non-Pharmacologic Therapy for Neurocardiogenic Syncope
|
PHASE2 |
View
|
